Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Those who dislike needles may still find that B12 pills are a convenient alternative
Regulatory and safety landscape Theres a lot of gray market activity
HIMS had been getting away with selling compounded injectable semaglutide in a post-shortage regulatory environment for over a year, largely uncontested
Patients should be aware that any access to retatrutide outside of a regulated clinical trial setting would be unlicensed and potentially unsafe
US$ 24.32
US$ 28.27
US$ 29.43
US$ 20.02
US$ 27.46
US$ 21.80
US$ 26.10
US$ 25.02
